MedXY
Not signed in Sign in / Register
Skip to content
medxy logo Medxy AI
  • Specialties
    • Allergy & Immunology
    • Anesthesiology
    • Cardiology
    • Critical Care
    • Dermatology
    • Diabetes & Endocrinology
    • Emergency Medicine
    • Family Medicine & Nutrition
    • Gastroenterology
    • General Surgery
    • Hematology-Oncology
    • HIV/AIDS
    • Infectious Diseases
    • Internal Medicine
    • Nephrology
    • Neurology
    • Nursing & care
    • OB/GYN & Women’s Health
    • Oncology
    • Ophthalmology
    • Orthopedics
    • Otorhinolaryngology
    • Pathology & Lab Medicine
    • Pediatrics
    • Plastic Surgery
    • Psychiatry
    • Public Health
    • Radiology
    • Respiratory
    • Rheumatology
    • Urology
  • iDoctor
  • Medical Calculators
  • Videos
  • Health Games
  • Specialties
    • Allergy & Immunology
    • Anesthesiology
    • Cardiology
    • Critical Care
    • Dermatology
    • Diabetes & Endocrinology
    • Emergency Medicine
    • Family Medicine & Nutrition
    • Gastroenterology
    • General Surgery
    • Hematology-Oncology
    • HIV/AIDS
    • Infectious Diseases
    • Internal Medicine
    • Nephrology
    • Neurology
    • Nursing & care
    • OB/GYN & Women’s Health
    • Oncology
    • Ophthalmology
    • Orthopedics
    • Otorhinolaryngology
    • Pathology & Lab Medicine
    • Pediatrics
    • Plastic Surgery
    • Psychiatry
    • Public Health
    • Radiology
    • Respiratory
    • Rheumatology
    • Urology
  • iDoctor
  • Medical Calculators
  • Videos
  • Health Games

Cesarean Section

Search medical newsFind research, conditions and clinical updates
  • Home
  • Cesarean Section
第一胎经阴道分娩后第二胎剖宫产:新生儿风险显著升高——来自 JUMODA 队列的研究发现
Posted inClinical Updates OB/GYN & Women's Health

Increased Neonatal Risks with Cesarean Delivery of Second Twin Following Vaginal Birth of First Twin: Insights from the JUMODA Cohort

Posted by By MedXY 11/09/2026
Cesarean delivery for the second twin after vaginal delivery of the first twin is linked to a threefold increase in severe neonatal morbidity and mortality. Key risk factors include absence of analgesia, transverse presentation, and low-volume delivery centers.
Read More
Quercetin as an Adjunct for Post-Cesarean Pain: Clinical Promise from a Randomized Controlled Trial
Posted inAnesthesiology General Surgery news OB/GYN & Women's Health Specialties

Quercetin as an Adjunct for Post-Cesarean Pain: Clinical Promise from a Randomized Controlled Trial

Posted by By MedXY 08/09/2025
Preoperative Quercetin significantly reduces post-cesarean pain and accelerates patient mobilization, offering a safe adjunct to current pain management protocols.
Read More

Take a game break

Explore a few games from MedXY.

Explore all games
  • Advancing Post-Stroke Upper Limb Assessment: The FULMA Single-Camera Markerless Motion Capture System
  • Evaluating the 0/1-Hour Cardiac Troponin Pathway: Safety Confirmed but No Reduction in Emergency Department Stay
  • Enhancing Adolescent STI Screening: A Multisite Primary Care Quality Improvement Initiative for Chlamydia and Gonorrhea
  • Differential Impact of Disease Activity on Bone Quality in Rheumatoid and Psoriatic Arthritis: A 7-Year Longitudinal HR-pQCT Study
  • Assessing Center-Level Variability in Clinical Data Updates for US Lung Transplant Candidates: Implications for Allocation Equity
  • About us
  • Contact us
  • MedXY story
  • Privacy Policy
  • Subscribe Now!

  • English
  • 日本語
  • Tiếng Việt
  • 中文

Alzheimer's disease artificial intelligence atrial fibrillation biomarkers breast cancer Cardiology cardiovascular disease cardiovascular risk case report chronic kidney disease clinical trial clinical trials critical care diabetes epidemiology GLP-1 receptor agonists heart failure hepatocellular carcinoma Hypertension immunotherapy inflammation machine learning MASLD mental health Mortality multiple myeloma myocardial infarction nutrition obesity older adults oncology Pediatrics precision medicine Pregnancy prognosis public health quality of life randomized clinical trial randomized controlled trial risk stratification SGLT2 inhibitors stroke targeted therapy type 1 diabetes type 2 diabetes

Your health, we care

Copyright 2026 — Medxy AI. All rights reserved.
Scroll to Top